Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure

Clinical and Experimental Obstetrics and Gynecology

Volumn 39, Issue 1, 2012, Pages 13-18

  Bonilla Musoles, F ^a   Castillo, J C ^a   Caballero, O ^a   Perez Panades J ^a   Bonilla, F ^a   Dolz, M ^a   Osborne, N ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSIDAD DE PANAMÁ   (Panama)

Author keywords

3D ultrasound; Anti Mu llerian hormone (AMH); Antral follicle count (AFC); AVC; Inverse mode; Low responders; VOCAL

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR;

ADULT; ANALYTICAL PARAMETERS; ANALYTICAL RESEARCH; ANTRAL FOLLICLE COUNT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; INFERTILITY THERAPY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OOCYTE; OVARIAN RESERVE; OVARY FOLLICLE; PREGNANCY RATE; PROGNOSIS; PROSPECTIVE STUDY;

EID: 84860878610     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Bukman A., Heineman M.J.: "Ovarian reserve testing and the use of prognostic models in patients with subfertility". Hum. Reprod. Update, 2001, 7, 581.
2. Tarin J.J., Ruiz A., Miró F., Bonilla-Musoles F., Pellicer A.: "Failed in vitro fertilization of human oocyces: a cytogenetic analisis". Fertil. Steril., 1991, 56, 290.
3. Pellicer A., Rubio C., Vidal F., Remohi J.: "In vitro fertilization plus preimplantation genetic diagnosis in patients with recurrent miscarriage: an analysis of chromosome abnormalities in human preimplantation embryos". Fertil. Steril., 1999, 71, 1033.
4. Ebner T., Sommergruber M., Moser M., Shebl O., Schreier-Lechner E., Tews G.: "Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles". Hum. Reprod., 2006, 8, 2022.
5. Scheffer G.J., Broekmans F.J.M., Dorland M.: "Antral follicle counts by transvaginal ultrasonography are related to age in women proven natural Fertility". Fertil. Steril., 1999, 72, 845.
6. Peñarrubia J.: "Etiologia y teorias sobre baja respuesta". In: Cuadernos de Medicina Reproductiva. Garcia-Velasco J.A. y Remohi J., Adalia (eds.), Madrid, 2007, 13, 9.
7. Bonilla-Musoles F., Dolz M., Moreno J., Raga F.: "Ovarian aging". In: Bonilla-Musoles F., Dolz M., Moreno J., Raga F. (eds.). Reproducción Asistida: Manejo clínico. Madrid, Panamericana. 2009.
8. Broer S.L., Mol B.W., Hendriks D., Broekmans F.J.: "The role of antimüllerian hormone in prediction of outcome after IVF: comparison with the antral follicle count". Fertil. Steril., 2009, 91, 705.
9. Fanchin R., Schonauer L.M., Righini C., Guibourdenche J., Frydman R., Taieb J.: "Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3". Hum. Reprod., 2003, 18, 323.
10. Fiçicioglu C., Kutlu T., Baglam E., Bakacak Z.: "Early follicular antimüllerian hormone as an indicator of ovarian reserve". Fertil. Steril., 2006, 85, 592.
11. Hazout A., Bouchard P., Seifer D.B., Aussage P., Junca A.M., Cohen-Bacrie P.: "Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B or estradiol". Fertil. Steril., 2004, 82, 1323.
12. La Marca A., Volpe A.: "The anti-müllerian hormone and ovarian cancer". Hum. Reprod. Update, 2007, 3, 265.
13. La Marca A., Broekmans F.J., Volpe A., Fauser B.C., Macklon N.S.: "Anti-Müllerian hormone (AMH): what do we still need to know?". Hum. Reprod., 2009, 24, 2264.
14. Muttukrishna S., Suharjono H., McGarrigle H., Sathanandan M.: "Inhibin B and anti-Müllerian hormone Markers of ovarian response in IVF/ICSI patients?". Br. J. Obstet. Gynaecol., 2004, 111, 1248.
15. Peñarrubia J., Fabregues F., Manau D., Creus M., Casals G., Casamitjana R. et al.: "Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles timulated with gonadotropin-releasing hormone agonist-gonadotropin treatment". Hum. Reprod., 2005, 20, 915.
16. Seifer D.B., MacLaughlin D.T., Christian B.P., Feng B., Shelden R.M.: "Early follicular serum müllerian inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles". Fertil. Steril., 2002, 77, 468.
17. Tremellen K.P., Kolo M., Gilmore A., Lekamge D.N.: "Anti- Müllerian hormone as a marker of ovarian reserve". Aust. NZ J. Obstet. Gynaecol., 2005, 45, 20.
18. Van Rooij I.A., Broekmans F.J., Te Velde E.R., Fauser B.C., Bancsi L.F., Te Jong F.H. et al.: "Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve". Hum. Reprod., 2002, 17, 3065.
19. La Marca A., Sighinolfi D., Radi C., Argento E., Baraldi A., Carducci Artensio G. et al.: "Anti-Müllerian hormona (AHM) as a predictive marker in assisted reproductive technology (ART)". Hum. Reprod. Update, 2010, 16, 113.
20. Cheng-Hsuan W., Yu-Ching C., Hsin-Hung W., Jyuer-Ger Y., YuJun C., Horng-Der T.: "Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients". J. Assist. Reprod. Genet., 2009, 26, 383.
21. Fanchin R., Schonauer L.M., Righini C., Frydman R., Taieb J.: "Serum anti-Müllerian dynamics during controlled ovarian hyperstimulation". Hum. Reprod., 2003, 18, 328.
22. Deutch T.D., Joergner A.I., Matson E.D.O., Oehninger C.D.S., Bocca A.S., Hoenigmann A.D. et al:. "Automated assessment of ovarian follicles using a novel three-dimensional ultrasound software". Fertil. Steril., 2009, 92, 1562.
23. Nardo L.G., Gelbaya T.A., Wilkinson H., Roberts S.A., Yates A., Penberton P. et al.: "Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization". Fertil. Steril., 2008, 90, 1.
24. Broekmans F.J., de Ziegler D., Howies C.M., Gougeon A., Trew G., Olivennes F.: "The antral follicle count: practical recommendations for better standardization". Fertil. Steril., 2010, 94, 1044.
25. Scheffer G.J., Broekmans F.J.M., Bancsi L.F., Habbema J.D., Looman C.W., Te Velde E.R.: "Quantitative transvaginal two- and three-dimensional sonography of the ovaries: Reproductibility of antral follicle counts". Ultrasound Obstet. Gynecol., 2002, 20, 270.
26. Broekmans F.J., Kwee J., Hendriks D.J., Mol B.W., Lambalk C.B.: "A systematic review of tests predicting ovarian reserve and IVF outcome". Hum. Reprod. Update, 2006, 12, 685.
27. Pellicer A., Ardiles G., Neuspiller F., Remohi J., Simón C., Bonilla-Musoles F.: "Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography". Fertil. Steril., 1998, 78, 671.
28. Dolz M., Osborne N., Bonilla-Musoles F.: "Polycystic ovarian syndrome: Assessment with color Doppler angiography and three-dimensional ultrasonography". J. Ultrasound Med., 1999, 18, 303.
29. Bonilla-Musoles F.: "Ecografía vaginal, Doppler y tridimensión en Obstetricia y Ginecología". Panamericana Edit. Madrid, 2000.
30. Bonilla-Musoles F.: "4D Ultrasound in Obstetrics". Madrid, Panamericana Edit., 2006.
31. Karande V.: "Managing and predicting low response to standard in vitro fertilization therapy: a review of the options". Mol. Cell. Endocrinol., 2005, 234, 81.
32. Hendricks D.J., Mol B.W., Bancsi L.F., Te Velde E.R., Broekmans F.J.: "Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level". Fertil. Steril., 2005, 83, 291.
33. Ruess M.L., Kline J., Santos R., Levin B., Timor-Tritsch I.: "Age and ovarian follicle pool assessed with transvaginal ultrasonography". Am. J. Obstet. Gynecol., 1996, 174, 624.
34. Chang M.I., Chiang C.H., Hsieh T.T., Soong Y., Hsu K.: "Use of the antral follicle count to predict the outcome of assisted reproductive technologies". Fertil. Steril., 1998, 69, 505.
35. Tomas C., Nuojua-Huttmen N., Martikainen H.: "Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization". Hum. Reprod., 1997, 12, 220.
36. Bancsi L.F., Broekmans F.J., Eijkemans M.J., De Jong F.H., Habbema J.D., De Velde E.R.: "Predictors of poor ovarian response in in-vitro fertilization: a prospective study comparing basal markers of ovarian reserve". Fertil. Steril., 2002, 77, 328.
37. Craig H., Syrop M.D., Brad Van Voorhis M.D.: "Use of ultrasound to predict and optimize outcomes of ovulation induction". In: Vishvanath C., Karande C.: Infertil. Reprod. Med. Clin. North Am., 2003, 14, 269.
38. McIlveen M., Skull J.D., Ledger W.L.: "Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population". Hum. Reprod., 2007, 22, 778.
39. Bancsi L.F., Broekmans F.J., Eijkemans M.J., de Jong F.H., Habbema J.D., te Velde E.R.: "Predictors of poor ovarian response in in-vitro fertilization: a prospective study comparing basal markers of ovarian reserve". Fertil. Steril., 2002, 77, 328.
40. Barad D.H., Weghofer A., Gleicher N.: "Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian fuction". Fertil. Steril., 2009, 91, 1553.
41. Frattarelli J.L., Levi A.J., Miller B.T., Segars J.H.: "A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization". Fertil. Steril., 2003, 80, 50.
42. Hendriks D.J., Mol B.W., Bancsi L.F., Te Velde E.R., Broekmans F.J.: "Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level". Fertil. Steril., 2005, 83, 291.
43. Jurema M.W., Bracero N.J., Garcia J.E.: "Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles". Fertil. Steril., 2003, 80, 1156.
44. Castillo J.C., De Leon G., Zelaya A., Raga F., Bonilla F. Jr., Bonilla-Musoles F.: "A donde vamos en Ultrasonidos? Un esfuerzo para ver la vida intraútero más claramente". Progresos Obstet. Ginecol., 2006, 49, 127.
45. Raine-Fenning NJ, Campbell BK, Clewes JS, Johnson IR. The interobserver reliability of ovarian volume measurement is improved with three-dimensional ultrasound, but dependent upon technique. Ultrasound Med Biol 2003; 29:1685-90. (Pubitemid 38091717)
46. Raine-Fenning N.J., Lam P.M.: "Assessment of ovarian reserve using the inversion mode. Picture of the month". Ultrasound Obstet. Gynecol., 2006, 27, 104.
47. Raine-Fenning N.J., Jayaprakasan K., Clewes J.S.: "Automated follicle tracking facilitates standardization and may improve work flow". Ultrasound Obstet. Gynecol., 2007, 30, 1015.
48. Raine-Fenning N., Jayaprakasan K., Clewes J., Joergner I., Bonaki S.D., Chamberlain S. et al.: "SonoAVC: a novel method of automatic volume calculation". Ultrasound Obstet. Gynecol., 2008, 31, 691.
49. Lass A., Skull J., McVeigh E., Margara R., Winston R.: "Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin". Hum. Reprod., 1997, 12, 294.